Sales@medsciencepharm.com    +86-396-2967988
Cont

Have any Questions?

+86-396-2967988

Jul 01, 2025

What are the effects of UK Urokinase CAS 9039 - 53 - 6 on gene expression?

Urokinase, identified by the CAS number 9039 - 53 - 6, is a significant enzyme that has been a subject of extensive research in the medical and biological fields. As a reliable supplier of UK Urokinase CAS 9039 - 53 - 6, I have witnessed the growing interest in understanding its various effects, especially on gene expression. In this blog, I will delve into the scientific aspects of how UK Urokinase impacts gene expression and explore the potential implications of these effects.

Understanding UK Urokinase CAS 9039 - 53 - 6

Urokinase is a serine protease that can be isolated from human urine or produced through recombinant DNA technology. It is well - known for its fibrinolytic activity, which makes it a valuable agent in the treatment of blood clots. UK Urokinase, specifically, has been recognized for its high - quality and consistent performance in various applications.

The enzyme works by converting plasminogen to plasmin, an enzyme that degrades fibrin, the main component of blood clots. However, recent studies have suggested that urokinase may have far - reaching effects beyond its fibrinolytic function, including influences on gene expression.

Mechanisms of Urokinase - Mediated Gene Expression Changes

Receptor - Mediated Signaling

Urokinase binds to its specific receptor, urokinase - type plasminogen activator receptor (uPAR). This binding event initiates a cascade of intracellular signaling pathways. For example, the interaction between urokinase and uPAR can activate mitogen - activated protein kinases (MAPKs), such as extracellular signal - regulated kinase (ERK), c - Jun N - terminal kinase (JNK), and p38. These kinases can translocate to the nucleus and phosphorylate transcription factors, which in turn regulate the expression of target genes.

UlinastatinGonadorelin Acetate Infertility Treatment

Proteolytic Activation of Growth Factors

Urokinase can proteolytically activate growth factors and cytokines. For instance, it can cleave and activate latent transforming growth factor - beta (TGF - β), a multifunctional cytokine that plays a crucial role in cell growth, differentiation, and extracellular matrix remodeling. Once activated, TGF - β can bind to its receptors and initiate a signaling pathway that leads to changes in gene expression. This activation of growth factors can have a profound impact on the transcriptional regulation of genes involved in cell proliferation, migration, and survival.

Epigenetic Modifications

There is emerging evidence that urokinase may also influence gene expression through epigenetic mechanisms. Epigenetic modifications, such as DNA methylation and histone acetylation, can alter the accessibility of DNA to transcription factors and RNA polymerase. Urokinase - mediated signaling pathways may affect the activity of enzymes involved in epigenetic modifications, leading to changes in the chromatin structure and ultimately gene expression.

Effects on Specific Genes and Pathways

Genes Involved in Cell Proliferation

Studies have shown that urokinase can upregulate genes associated with cell proliferation, such as cyclin D1. Cyclin D1 is a key regulator of the cell cycle, promoting the transition from the G1 to the S phase. By increasing the expression of cyclin D1, urokinase can stimulate cell proliferation, which may be beneficial in tissue repair and regeneration processes.

Genes Related to Inflammation

Urokinase can also modulate the expression of genes involved in inflammation. It can upregulate the expression of pro - inflammatory cytokines, such as interleukin - 6 (IL - 6) and tumor necrosis factor - alpha (TNF - α). These cytokines play important roles in the immune response and can recruit immune cells to the site of injury or infection. On the other hand, urokinase may also downregulate anti - inflammatory genes, which can lead to an imbalance in the immune response if not properly regulated.

Genes Associated with Metastasis

In the context of cancer, urokinase has been linked to the regulation of genes involved in metastasis. It can upregulate genes such as matrix metalloproteinases (MMPs), which are enzymes that degrade the extracellular matrix, facilitating tumor cell invasion and migration. Additionally, urokinase can influence the expression of genes related to angiogenesis, the formation of new blood vessels, which is essential for tumor growth and metastasis.

Implications of Urokinase - Induced Gene Expression Changes

Therapeutic Implications

The effects of UK Urokinase on gene expression have significant therapeutic implications. In the treatment of blood clots, the ability of urokinase to modulate gene expression may contribute to the repair of damaged blood vessels and surrounding tissues. By promoting the expression of genes involved in cell proliferation and tissue regeneration, urokinase can enhance the healing process.

In cancer treatment, understanding the role of urokinase in gene expression may lead to the development of novel therapeutic strategies. For example, inhibitors of urokinase or its receptor may be used to block the signaling pathways that promote tumor growth and metastasis.

Diagnostic Implications

Changes in gene expression profiles induced by urokinase may also serve as diagnostic markers. For instance, the upregulation of certain genes in response to urokinase treatment may indicate the activation of specific biological pathways, which can be used to assess the effectiveness of treatment or predict disease prognosis.

Related Products and Their Significance

As a supplier of UK Urokinase CAS 9039 - 53 - 6, I also offer other high - quality products that are relevant to the field of medical research and treatment. Gonadorelin Acetate Infertility Treatment is a product that has been widely used in the treatment of infertility. It acts on the pituitary gland to stimulate the release of gonadotropins, which are essential for ovulation and spermatogenesis.

Ulinastatin is another important product. It is a protease inhibitor that has anti - inflammatory, anti - shock, and organ - protective effects. Ulinastatin can regulate the immune response and protect cells from damage caused by excessive protease activity.

Cetrorelix Acetate For Reproductive Medicine is a synthetic decapeptide that is used in assisted reproductive technology. It acts as a gonadotropin - releasing hormone (GnRH) antagonist, preventing premature luteinizing hormone (LH) surges and improving the success rate of in vitro fertilization (IVF).

Conclusion and Call to Action

The effects of UK Urokinase CAS 9039 - 53 - 6 on gene expression are complex and multifaceted. Understanding these effects can provide valuable insights into the biological functions of urokinase and open up new avenues for therapeutic and diagnostic applications.

If you are interested in learning more about UK Urokinase or any of our other products, I encourage you to reach out for further discussion. Whether you are a researcher looking for high - quality reagents or a medical professional seeking effective treatment options, we are here to provide you with the best solutions. Contact us to start a procurement negotiation and discover how our products can meet your specific needs.

References

  1. Blasi F, Carmeliet P. The urokinase - type plasminogen activator system in cancer metastasis: a review. Cancer Cell. 2002;2(3):207 - 212.
  2. Dano K, Andreasen PA, Grøndahl - Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res. 1985;44:139 - 266.
  3. Rabbani SA, Glazer RI. Urokinase plasminogen activator: a regulator of cell signaling and tumor progression. Oncogene. 2004;23(45):7414 - 7425.

Send Inquiry